4671 related articles for article (PubMed ID: 6629343)
1. Prognosis in patients with thin malignant melanoma: influence of regression.
McGovern VJ; Shaw HM; Milton GW
Histopathology; 1983 Sep; 7(5):673-80. PubMed ID: 6629343
[TBL] [Abstract][Full Text] [Related]
2. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
Milton GW; Shaw HM; Farago GA; McCarthy WH
Br J Surg; 1980 Aug; 67(8):543-6. PubMed ID: 7427045
[TBL] [Abstract][Full Text] [Related]
3. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis.
Park KG; Blessing K; McLaren KM; Watson AC
Br J Plast Surg; 1993 Oct; 46(7):607-10. PubMed ID: 8252271
[TBL] [Abstract][Full Text] [Related]
4. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
[TBL] [Abstract][Full Text] [Related]
5. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.
Cooper PH; Wanebo HJ; Hagar RW
Arch Dermatol; 1985 Sep; 121(9):1127-31. PubMed ID: 4037837
[TBL] [Abstract][Full Text] [Related]
6. Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
Griffiths RW; Briggs JC
Br J Plast Surg; 1984 Oct; 37(4):507-13. PubMed ID: 6498389
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous melanomas that defy conventional prognostic indicators.
McCarthy WH; Shaw HM; McCarthy SW; Rivers JK; Thompson JF
Semin Oncol; 1996 Dec; 23(6):709-13. PubMed ID: 8970591
[TBL] [Abstract][Full Text] [Related]
8. Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases.
Søndergaard K; Hou-Jensen K
Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):241-7. PubMed ID: 3936263
[TBL] [Abstract][Full Text] [Related]
9. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
10. Thin malignant melanomas and recurrence potential.
Shaw HM; McCarthy WH; McCarthy SW; Milton GW
Arch Surg; 1987 Oct; 122(10):1147-50. PubMed ID: 3662794
[TBL] [Abstract][Full Text] [Related]
11. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases.
Shaw HM; McCarthy SW; McCarthy WH; Thompson JF; Milton GW
Histopathology; 1989 Sep; 15(3):257-65. PubMed ID: 2807184
[TBL] [Abstract][Full Text] [Related]
12. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of thick cutaneous melanoma of the trunk and extremity.
Coit D; Sauven P; Brennan M
Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of a polypoid configuration in malignant melanoma.
McGovern VJ; Shaw HM; Milton GW
Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
16. Recurrent malignant melanoma: the identification of prognostic factors to predict survival.
Reintgen DS; Cox C; Slingluff CL; Seigler HF
Ann Plast Surg; 1992 Jan; 28(1):45-9. PubMed ID: 1642405
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of level V malignant melanoma.
Bear HD; Neifeld JP; Kay S
Cancer; 1985 Mar; 55(6):1167-71. PubMed ID: 3971289
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of cutaneous malignant melanoma related to histopathological criteria of primary tumour.
Drzewiecki KT; Christensen HE; Ladefoged C; Poulsen H
Scand J Plast Reconstr Surg; 1980; 14(3):229-34. PubMed ID: 7209408
[TBL] [Abstract][Full Text] [Related]
19. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.
Gromet MA; Epstein WL; Blois MS
Cancer; 1978 Nov; 42(5):2282-92. PubMed ID: 719608
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis.
Søndergaard K; Schou G
Virchows Arch A Pathol Anat Histopathol; 1985; 408(2-3):249-58. PubMed ID: 3936264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
